“What’s New in ME/CFS?” Why Heterogeneity is the Key to Breakthroughs
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we know about this disease. Recently, we spoke with Dr. Per Sjögren and Dr. Bo Bertilson, Associate Professors […]
Why Public Comments Matter: How Solve Protects Patients Before Policies and Trials are Set in Stone
When an organization, like a government agency, company, or nonprofit, considers a big change or launches a new initiative, it may ask for feedback from the public during a public […]
Webinar Replay: GLP-1 Drugs to Reduce Symptoms in People with ME/CFS and Identify Disease Subgroups
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the natural GLP-1 hormone, which helps regulate insulin levels. Thus, these medicines help control blood sugar […]
Solve Science Spotlight: Systematic Underfunding of Long Covid, ME/CFS, and Other Debilitating Diseases That Disproportionately Affect Women
Dr. Karen Bonuck is professor of family and social medicine at Albert Einstein College of Medicine. Her research uses diverse methods to understand the burden of different disabilities among children […]
Action Alert: Another appropriations effort that directly impacts ME/CFS
A quick note to loop you in on another appropriations effort we’re in support of – one that directly impacts our ME/CFS community, with a deadline tonight! Senators Markey (D-MA), […]
Solve CEO Emily Taylor Selected for Milken Institute Leadership Program
We’re proud to announce that Solve CEO Emily Taylor has been selected for the 2026–2027 cohort of FasterCures’ LeadersLink—a leadership program of the Milken Institute focused on accelerating biomedical progress. […]
This Week in “What’s New in ME/CFS?” Dr. Avik Roy & Dr. Gunnar Gottschalk (Simmaron Research)
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do about this disease. Recently, we spoke with Dr. Avik Roy, Chief Scientific Officer at Simmaron […]
Advocacy Week Starts Monday and This Year is Different
Advocacy Week 2026 starts this Monday, March 23rd, and this year we’re doing something different. Instead of meeting with legislators, we’re working with the systems that shape what medical providers […]
A Quick Guide to Advocacy Week 2026
Solve M.E. and #MEAction are joining forces for a week of coordinated action designed to move ME/CFS from optional knowledge to the standard of care in clinical training — and […]
Recognizing Long Covid Awareness Day: Resources for You
Every year on March 15, our community pauses to recognize Long Covid Awareness Day—a day to acknowledge the millions of people whose lives have been changed by long-term illness following […]
Join the Fight for Federal Research Funding and Medical Education for ME/CFS
Appropriations season is moving fast this year, and we are proud to share that Solve M.E. has submitted our FY27 appropriations letters to both the House and Senate Labor-HHS and […]
Registration Open for ME/CFS Advocacy Week 2026
Dear friends, This year, Solve M.E. & #MEAction are partnering on a medical education initiative. As we began planning Advocacy Week this year, we took a step back and asked: […]